2021
DOI: 10.2147/cia.s312129
|View full text |Cite
|
Sign up to set email alerts
|

A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease

Abstract: Atherosclerosis contributes substantially to cardiovascular mortality in patients with chronic kidney disease (CKD). But precise risk model for subclinical atherosclerosis in the CKD population is still lacking. The study aimed to develop and validate a nomogram for screening subclinical atherosclerosis among CKD patients without dialysis. Patients and Methods: A total of 1452 CKD stage 1-5 has been recruited in this crosssectional study. Subclinical atherosclerosis was diagnosed with carotid ultrasonography. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…Significant advances have been made in the novel biomarker identification for AS development and progression. A developed logistic model based on the well-known AS risk factors such as gender, age, hypertension, and diabetes shows excellent predictive ability (AUC = 0.808) and might have a significant clinical implication for detecting subclinical atherosclerosis in patients with chronic kidney disease [ 40 ]. Additionally, circulating miRNA-933 has proven to be related with hyperlipidemia (AUC = 0.739) and atherosclerosis (AUC = 0.703) [ 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…Significant advances have been made in the novel biomarker identification for AS development and progression. A developed logistic model based on the well-known AS risk factors such as gender, age, hypertension, and diabetes shows excellent predictive ability (AUC = 0.808) and might have a significant clinical implication for detecting subclinical atherosclerosis in patients with chronic kidney disease [ 40 ]. Additionally, circulating miRNA-933 has proven to be related with hyperlipidemia (AUC = 0.739) and atherosclerosis (AUC = 0.703) [ 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…It is recommended to limit sodium intake to less than 2,300 mg per day (or even lower for certain individuals) [ 61 ]. If prescribed medication for HTN, it is essential to take it as directed by a healthcare professional and attend regular check-ups [ 61 , 62 ]. Regular visits with a healthcare professional can help monitor blood pressure levels and identify any potential risk factors for HTN [ 61 , 62 ].…”
Section: Reviewmentioning
confidence: 99%